Weijing Sun, MD

Sprint Professor of Medical Oncology and director of the Division of Medical Oncology

University of Kansas Medical Center, and associate director of the University of Kansas Cancer Center

Published Articles (1)

Pancreatic Cancer: A RAS Inhibitor Nearly Doubles Survival, and a KRAS Vaccine Shows Real Promise

August 7, 2026

Pancreatic cancer has been a difficult disease to move the needle on: median survival with first-line chemotherapy has hovered around six months for decades, and targeted therapy has largely unsuccess here despite working elsewhere.